New Zealand markets closed

PFE Jan 2025 50.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.15000.0000 (0.00%)
As of 11:37AM EST. Market open.
Full screen
Previous close0.1500
Expiry date2025-01-17
Day's range0.1500 - 0.2500
Contract rangeN/A
Open interest15.09k
  • Motley Fool

    Pfizer's Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy?

    On Dec. 1, Pfizer (NYSE: PFE) reported some less-than-great news to investors. In short, its latest attempt at developing a drug to compete with Novo Nordisk's blockbuster medicine Ozempic will not be advancing into late-stage clinical trials. Now, the company's bid to capture portions of the extremely lucrative type 2 diabetes and obesity drug markets looks like it's in trouble.

  • Insider Monkey

    10 Cheap Dividend Stocks with High Yields

    In this article, we discuss 10 cheap dividend stocks with high yields. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Cheap Dividend Stocks with High Yields. In 2022, value stocks did better than growth stocks, marking the first time of value outperformance […]

  • Zacks

    Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod

    AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.